Top 10 3D Printing and Advanced Manufacturing Capital Raises and Investors in the U.S. – August 1st – 31st, 2026
Several interesting transactions closed in the 3D Printing and Advanced Manufacturing sector over the past month. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
PE Growth/Expansion
- Plushie Planet, a designer plush and art toy manufacturer that creates AI companions for emotional companionship, received $10 million of development capital.
Buyout/LBO
- Midwest Dental Arts, a dental restorations manufacturer that produces custom-fit crowns, bridges, and implant prosthetics for dental professionals, acquired by Pan-Am Dental through an LBO.
- ZYCI, a precision CNC machining and additive manufacturing provider that produces complex components and prototypes for mission-critical industries, acquired by Fulton Asset Management through an LBO.
Later Stage VC
- Lyrata, a three-dimensional printed grow-media technology developer that helps indoor growers cultivate crops with greater efficiency and reduced environmental impact, raised venture funding from Desjardins Group, Canso Innovations and Next.
- Multibeam, a semiconductor lithography equipment manufacturer that provides maskless production solutions for integrated circuits, raised venture funding from Super Capital Group.
- , a digital elastomer 3D printing systems manufacturer that enables mass customization and complex product manufacturing, raised $2.2 million of Series A venture funding.
- Cherry (Multimedia and Design Software), a spatial computing software developer that enables immersive three-dimensional experiences on the open web, raised venture funding from North 50 Venture Capital.
Early Stage VC
- Élisa, a 3D scene design platform developer that uses generative AI to automate environment creation through natural language prompts, raised venture funding from AQC Capital.
- Hike Medical, a device-based care operating system developer that automates care workflows and supports in-house 3D-printed manufacturing, raised $22.5 million of Series A venture funding in a deal led by Saga Ventures.
Seed Round
- Limber, a prosthetic and orthotic device developer that uses three-dimensional printing to produce personalized prosthetic products, raised an additional $135,343 of Seed funding.
#castleplacement #capitalraising #privateequity #venturecapital #investment #3DPrinting #AdvancedManufacturing
John Silvestri
Managing Director
Finance, strategy and capital markets executive. Originated structured and executed, as principal, agent and underwriter, over $4 billion of public and private, structured and project finance transactions. Industry expertise includes Energy and Power, Technology/Fintech/Digital, Sponsor, Transportation and Infrastructure, Consumer, Industrials and Agriculture, Banking, and Specialty Finance. Companies ranging from small to large, leveraged, high grade, venture, SPV’s and project finance. Transaction expertise across capital structure includes public and private bonds, equity, structured and direct investments, and unitranche. Leveraged finance includes senior/sub, bridge, acquisition, mezzanine, equity co-investment, and re-capitalizations. Previously, founder of an advisory and a direct investment business, Managing Director and Co-head of Investment Banking at Altamar Capital, and Director and Head of High Yield Capital Markets in New York for Barclays Capital. BS in Management from SUNY Buffalo. MBA from Fordham Gabelli Business School. FINRA Series 7 and 63 licenses.
- Email: jsilvestri@castleplacement.com
- (C) (203) 803-9861
 John SilvestriManaging Director |
Please contact me if you have any questions or would like to discuss your capital raise:
Email: jsilvestri@castleplacement.com
(C) (203) 803-9861
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
